Rchr
J-GLOBAL ID：201801012279050912
Update date: Aug. 17, 2023
Sato Masakazu
Sato Masakazu
Affiliation and department：
Research field (1)：
Obstetrics and gynecology
Research theme for competitive and other funds (3)：
- 2019 - 2021 Study of the Clinical Significance of Metabolism-related Genes in Ovarian High-grade Serous Carcinoma
- 2016 - 2019 Cervical cancer stem cell model derived from iPS cells to investigate new therapeutic targets
- 2016 - 2018 The study about omega-3 fatty acids and their metabolites as preventive drugs for premature birth
Papers (29)：
-
Masakazu Sato, Sho Sato, Daisuke Shintani, Mieko Hanaoka, Aiko Ogasawara, Maiko Miwa, Akira Yabuno, Akira Kurosaki, Hiroyuki Yoshida, Keiichi Fujiwara, et al. Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma. BMC cancer. 2022. 22. 1. 59-59
-
Masakazu Sato, Daisuke Shintani, Mieko Hanaoka, Sho Sato, Maiko Miwa, Aiko Ogasawara, Akira Yabuno, Akira Kurosaki, Hiroyuki Yoshida, Keiichi Fujiwara, et al. A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm. Molecular and clinical oncology. 2021. 15. 4. 207-207
-
Machiko Kojima, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Shinya Oki, Asako Kukita, Akira Kawata, Harunori Honjoh, Yoshiko Kawata, et al. The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells. Oncology letters. 2020. 20. 5. 153-153
-
Masakazu Sato, Minako Koizumi, Minoru Nakabayashi, Kei Inaba, Yu Takahashi, Natsuki Nagashima, Hiroshi Ki, Nao Itaoka, Chiharu Ueshima, Maki Nakata, et al. Computer vision for total laparoscopic hysterectomy. Asian journal of endoscopic surgery. 2019. 12. 3. 294-300
-
Asako Kukita, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu, Miku Wada, Harunori Honjoh, Yoshiko Kawata, Machiko Kojima, et al. Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas. Biochemical and biophysical research communications. 2019. 513. 2. 340-346
ｍore...
MISC (63)：
-
佐藤 雅和. 今日の話題 医師業務負担軽減のための診療科データベースの構築. 産婦人科の実際. 2023. 72. 4. 423-429
-
鈴木 由梨奈, 堀江 弘二, 稲葉 洋文, 神田 蘭香, 佐藤 雅和, 天神林 友梨, 廣瀬 佑輔, 宮坂 亞希, 横田 治重. オラパリブ維持療法後のプラチナ製剤再投与の効果についての検討. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 204-204
-
天神林 友梨, 稲葉 洋文, 神田 蘭香, 佐藤 雅和, 廣瀬 佑輔, 鈴木 由梨奈, 宮坂 亞希, 堀江 弘二, 横田 治重. 子宮内膜症に由来した卵巣発生の低悪性度内膜間質肉腫の一例. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 284-284
-
廣瀬 佑輔, 稲葉 洋文, 神田 蘭香, 佐藤 雅和, 天神林 友梨, 鈴木 由梨奈, 宮坂 亞希, 堀江 弘二. 当院での初回卵巣癌維持療法におけるニラパリブの使用実績. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 286-286
-
佐藤 雅和, 堀江 弘二, 稲葉 洋文, 神田 蘭香, 廣瀬 佑輔, 天神林 友梨, 鈴木 由梨奈, 宮坂 亞希, 横田 治重. Precision Medicine時代における診療科データベースの入力支援システムの構築. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 301-301
ｍore...
Education (1)：
- 2014 - 2018 The University of Tokyo Graduate School of Medicine Department of Obstetrics and Gynecology
Professional career (1)：
Return to Previous Page
